Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581880 · ClinicalTrials.gov registry record
Measuring Hope and Hopelessness in Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 288
- Enrollment target
NCT00581880: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00581880 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581880 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 288 participants
- Enrollment target
Study Summary
The purpose of this study is to develop an accurate and useful way of measuring patients' thoughts and feelings about hope and hopelessness as they relate to their illness. Doctors and psychologists from Memorial Sloan-Kettering Cancer Center, Calvary Hospital, the Peter MacCallum Cancer Centre, and Fordham University are working together to design a new measure. Findings from this research will help us study the nature of illness and develop improved methods of diagnosis and treatment. We hope what we learn from you will help us learn more about how to care better for patients with cancer and other severe illnesses.
Interventions
- BEHAVIORAL questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581880
The ClinicalTrials.gov registry entry for NCT00581880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaires is the first listed.
NCT00581880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581880 about?
NCT00581880 is a clinical study titled "Measuring Hope and Hopelessness in Cancer". The purpose of this study is to develop an accurate and useful way of measuring patients' thoughts and feelings about hope and hopelessness as they relate to their illness. Doctors and psychologists from Memorial Sloan-Kettering Cancer Center, Calvary Hospital, the Peter MacCallum Cancer Centre, and...
What is the current status of trial NCT00581880?
This trial is currently completed. The enrollment target is 288 participants. The study started on 2005-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00581880?
The interventions under investigation include: questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00581880?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.